Fresh analysis reveals that patients who discontinue blockbuster slimming jabs like semaglutide or tirzepatide can put back on lost weight much more quickly than those who end traditional lifestyle programs.
Research printed in a leading medical journal shows that while obese individuals can lose substantial amounts of their total mass while using the jabs, the mass comes back at an average rate of nearly a kilo each month after stopping.
"People using such drugs should be informed of the risk of quick rebound weight gain when the treatment is stopped," stated researcher Dr. Susan Jebb.
This pace of regain implies a reversion to starting weight in about a year and a half.
Analyzing Treatments
The analysis, which examined dozens of trials involving thousands of patients, contrasted the outcomes of the injectable medications with other pills.
Scientists note that individuals who lose weight through dieting typically have a more gradual creep back—approximately 100 grams monthly—once they finish.
Understanding the Rapid Regain
Experts suggest the way of the jabs explains the heightened regain.
GLP-1 drugs copy a natural hormone called GLP-1, which moderates hunger.
"Artificially providing the hormone levels far above than the body's typical production might result in the body to produce less of its own natural GLP-1, and may also reduce sensitivity to its actions," noted Dr. Adam Collins, a nutrition specialist.
"Stopping of this medication means hunger is no longer kept in check, making excessive eating a significant risk."
A Lifelong Disease?
Medical guidelines suggest the injections for people with weight-linked health risks, accompanied by recommended diet and exercise modifications.
A number of clinicians argue that, considering the high risk of relapse, the therapy might need to be life-long.
This view is reinforced by pharmaceutical companies, who say that the findings "emphasize the long-term character of obesity," similar to managing diseases like hypertension.
User Testimonies
Users who have discontinued the medication explain a intense return of appetite.
"It was like a switch activating and you're instantly extremely hungry," described an individual.
The struggle is exacerbated if individuals have not established lasting dietary or behavioural modifications during therapy.
Growing Use
Figures indicate that millions of people in the UK have used weight-loss jabs in the past year, with demand remaining high.
- Adoption is more common among women compared to males.
- The 40s and 50s demographic shows the highest usage rates.
- Many obtain the drugs through private prescriptions rather than the NHS.
Ultimately, experts stress that while the jabs are potent agents for shedding pounds, they are not a permanent solution and long-term success hinges on ongoing behavioural management.
